Results 181 to 190 of about 11,886 (196)

Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders

Clinical and Experimental Immunology, 2017
Rolf Weimer, B Hoppe, R Büscher
exaly  

Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use

Pediatric Nephrology, 2018
Jack Wetzels, , Kioa Wijnsma
exaly  

Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review

International Journal of Hematology, 2016
Osamu Miura, Kensuke Usuki, Naoyuki Miyasaka   +2 more
exaly  

Disseminated Gonococcal Infections in Patients Receiving Eculizumab: A Case Series

Clinical Infectious Diseases, 2019
Kyle Bernstein, Robert Kirkcaldy, Winston Abara   +2 more
exaly  

RECOMBINANT GLYCOSYLATED ECULIZUMAB AND ECULIZUMAB VARIANTS

2017
ANDRIEN BRUCE, HUNTER JEFFREY, MALANSON HUNTER   +2 more
openaire   +5 more sources

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis

Muscle and Nerve, 2019
Maurizio Inghilleri, John Vissing, Josef Bednarik   +2 more
exaly  

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation, 2016
Tsuyoshi Fukuda, Sonata Jodele, Jens Goebel   +2 more
exaly  

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome

Kidney International Reports, 2019
Fadi Fakhouri, Franz Schaefer, David Cohen   +2 more
exaly  

Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn

Immunobiology, 2015
Vedran ŠTEFANOVIC, Ole-Lars Brekke, Randi Fykse Hallstensen   +2 more
exaly  

Eculizumab in pregnancy: a narrative overview

Journal of Nephrology, 2018
Laura Sarno, Giuseppe Maruotti, Domenico Russo   +2 more
exaly